Due to the impact of COVID-19, the Mitsui Chemicals Group’s business results for the full financial year look set to show lower earnings than in the last few years. “We have sought to overcome these difficulties through operations that emphasize cash flow and careful selection of investments. At the same time, to speed up the transformation of our business portfolio, we have implemented such aggressive measures as M&A in our target domains. We have also set to work on strengthening our Basic Materials domain with a view to improving income fluctuations and raising earnings,” Hashimoto Osamu, President  & CEO, Mitsui Chemicals, said to Group employees in a New Year Greetings.

While the situation is unpredictable, there are signs that demand is picking up in major industries, and our business performance is on track for recovery. Going forward, our plan is to continue undertaking proactive investment aimed at transforming our business portfolio – with a primary focus on the Health Care and ICT sectors, where further growth is anticipated, he added.

Commenting on 2021, Osamu said that the company will redefine its vision with an eye to the world of 2030, share our roadmap for bringing the vision to fruition with the whole group and embark on implementing it. “We will establish a new dedicated organization within the company to promote digitalization in all fields in an integrated manner. We will accelerate efforts throughout the company to achieve net zero greenhouse gas emissions by 2050,” he added.